AI assistant
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2013
May 29, 2013
30339_dirs_2013-05-29_97cea2a3-8b59-4556-a64a-5ddc479416e8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-05-23
Reporting Person: MOREL DONALD E JR (Chair of the Board & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-05-23 | Common Stock | M | 100825.0000 | $41.7000 | Acquired | 603993.4076 | Direct |
| 2013-05-23 | Common Stock | M | 96576.0000 | $44.9700 | Acquired | 700569.4076 | Direct |
| 2013-05-23 | Common Stock | F | 79142.0000 | $67.6100 | Disposed | 621427.4076 | Direct |
| 2013-05-23 | Common Stock | F | 79995.0000 | $67.6100 | Disposed | 541432.4076 | Direct |
| 2013-05-28 | Common Stock | S | 5000.0000 | $68.0390 | Disposed | 536432.4076 | Direct |
| 2013-05-28 | Common Stock | S | 5000.0000 | $67.7030 | Disposed | 531432.4076 | Direct |
| 2013-05-24 | Common Stock | A | 18.8400 | $67.3800 | Acquired | 20527.2048 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-05-23 | Stock Option (Right to Buy) | $41.7000 | M | 100825.0000 | Disposed | 2018-02-26 | Common Stock (100825.0000) | Direct |
| 2013-05-23 | Stock Option (Right to Buy) | $44.9700 | M | 96576.0000 | Disposed | 2018-02-27 | Common Stock (96576.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1335.6398 | Indirect |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.48 to $68.30, inclusive. The reporting person undertakes to provide to any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in foonotes (1) and (2) to this Form 4.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.45 to $67.98, inclusive.